185 related articles for article (PubMed ID: 19201737)
41. CD24 expression has a prognostic impact in breast carcinoma.
Athanassiadou P; Grapsa D; Gonidi M; Athanassiadou AM; Tsipis A; Patsouris E
Pathol Res Pract; 2009; 205(8):524-33. PubMed ID: 19243896
[TBL] [Abstract][Full Text] [Related]
42. A comparative and evaluative study of two cytological grading systems in breast carcinoma with histological grading: an important prognostic factor.
Pandey P; Dixit A; Chandra S; Kaur S
Anal Cell Pathol (Amst); 2014; 2014():767215. PubMed ID: 25763344
[TBL] [Abstract][Full Text] [Related]
43. Is pleomorphic lobular carcinoma really a distinct clinical entity?
Buchanan CL; Flynn LW; Murray MP; Darvishian F; Cranor ML; Fey JV; King TA; Tan LK; Sclafani LM
J Surg Oncol; 2008 Oct; 98(5):314-7. PubMed ID: 18668643
[TBL] [Abstract][Full Text] [Related]
44. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas.
Le Doussal V; Tubiana-Hulin M; Friedman S; Hacene K; Spyratos F; Brunet M
Cancer; 1989 Nov; 64(9):1914-21. PubMed ID: 2551477
[TBL] [Abstract][Full Text] [Related]
45. Correlation of nuclear morphometry of breast cancer in histological sections with clinicopathological features and prognosis.
Abdalla F; Boder J; Markus R; Hashmi H; Buhmeida A; Collan Y
Anticancer Res; 2009 May; 29(5):1771-6. PubMed ID: 19443402
[TBL] [Abstract][Full Text] [Related]
46. The limited prognostic value of measuring and grading small invasive breast carcinomas: the whole sick lobe versus the details within it.
Tot T
Med Sci Monit; 2006 Aug; 12(8):RA170-5. PubMed ID: 16865079
[TBL] [Abstract][Full Text] [Related]
47. [Reproducibility of histoprognostic grades of invasive breast cancer].
Jacquemier J; Charpin C
Ann Pathol; 1998 Nov; 18(5):385-90. PubMed ID: 9864574
[TBL] [Abstract][Full Text] [Related]
48. Prognostic differences of World Health Organization-assessed mitotic activity index and mitotic impression by quick scanning in invasive ductal breast cancer patients younger than 55 years.
Skaland I; van Diest PJ; Janssen EA; Gudlaugsson E; Baak JP
Hum Pathol; 2008 Apr; 39(4):584-90. PubMed ID: 18291440
[TBL] [Abstract][Full Text] [Related]
49. Rate of 14CO2 production from variously labeled forms of [14C]glucose in human breast invasive ductal carcinoma tissues.
Yan SH; Wallon J; Mayaudon J
IUBMB Life; 1999 Oct; 48(4):409-11. PubMed ID: 10632570
[TBL] [Abstract][Full Text] [Related]
50. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
Faratian D; Munro A; Twelves C; Bartlett JM
Histopathology; 2009 Jan; 54(2):254-7. PubMed ID: 19207951
[TBL] [Abstract][Full Text] [Related]
51. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
Sullivan PS; Apple SK
Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
[TBL] [Abstract][Full Text] [Related]
52. RET finger protein expression in invasive breast carcinoma: relationship between RFP and ErbB2 expression.
Tezel GG; Uner A; Yildiz I; Guler G; Takahashi M
Pathol Res Pract; 2009; 205(6):403-8. PubMed ID: 19232840
[TBL] [Abstract][Full Text] [Related]
53. Histologic grading of breast cancer: linkage of patient outcome with level of pathologist agreement.
Dalton LW; Pinder SE; Elston CE; Ellis IO; Page DL; Dupont WD; Blamey RW
Mod Pathol; 2000 Jul; 13(7):730-5. PubMed ID: 10912931
[TBL] [Abstract][Full Text] [Related]
54. Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma.
Reena RM; Mastura M; Siti-Aishah MA; Munirah MA; Norlia A; Naqiyah I; Rohaizak M; Sharifah NA
Ann Diagn Pathol; 2008 Oct; 12(5):340-3. PubMed ID: 18774496
[TBL] [Abstract][Full Text] [Related]
55. Intraoperative evaluation of sentinel lymph nodes in invasive lobular carcinoma of the breast.
Taras AR; Hendrickson NA; Pugliese MS; Lowe KA; Atwood M; Beatty JD
Am J Surg; 2009 May; 197(5):643-6; discussion 646-7. PubMed ID: 19393357
[TBL] [Abstract][Full Text] [Related]
56. Grading system for blood vessel tumor emboli of invasive ductal carcinoma of the breast.
Sugiyama M; Hasebe T; Shimada H; Takeuchi H; Shimizu K; Shimizu M; Yasuda M; Ueda S; Shigekawa T; Osaki A; Saeki T
Hum Pathol; 2015 Jun; 46(6):906-16. PubMed ID: 25890786
[TBL] [Abstract][Full Text] [Related]
57. Application of the Scarff-Bloom-Richardson tumor grading system to fine-needle aspirates of the breast.
Howell LP; Gandour-Edwards R; O'Sullivan D
Am J Clin Pathol; 1994 Mar; 101(3):262-5. PubMed ID: 8135179
[TBL] [Abstract][Full Text] [Related]
58. Prognostic factors in infiltrating lobular carcinoma.
Makhija PS; Rameshkumar K; Chinoy RF
Indian J Pathol Microbiol; 2001 Jul; 44(3):315-9. PubMed ID: 12024921
[TBL] [Abstract][Full Text] [Related]
59. Distant metastasis after radical treatment of breast cancer: risk factors and their prognostic relevance in 378 consecutive patients.
Daskalova I; Popovska S; Betova T; Velkova A; Ivanova N; Baitchev G; Delijski T
J BUON; 2009; 14(2):229-33. PubMed ID: 19650171
[TBL] [Abstract][Full Text] [Related]
60. The reproducibility of histological parameters employed in the novel binary grading systems of endometrial cancer.
Gemer O; Uriev L; Voldarsky M; Gdalevich M; Ben-Dor D; Barak F; Anteby EY; Lavie O
Eur J Surg Oncol; 2009 Mar; 35(3):247-51. PubMed ID: 18775628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
